Risk factors for developing cardiac toxicities in cancer patients treated with panitumumab combination therapy.
Sign Up to like & getrecommendations! Published in 2020 at "Future oncology"
DOI: 10.2217/fon-2020-0050
Abstract: Aim: To evaluate the incidence and risk of cardiac toxicities associated with panitumumab in advanced cancer of Caucasian patients. Materials & methods: The incidence of cardiac toxicity was assessed by simple incidence rates and rates… read more here.
Keywords: risk; therapy; developing cardiac; risk factors ... See more keywords